JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A5166 Ondansetron HCl

Target: 5-HT3 Receptors

Summary: 5-HT3 receptor antagonist

insoluble in EtOH; insoluble in H2O; ≥33.04 mg/mL
A8496 Paliperidone

Target: 5-HT2 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|Histamine H1 Receptors

Summary: Dopamine receptor antagonist

insoluble in H2O; insoluble in EtOH; ≥10.662 mg/mL
A8537 Thioridazine HCl

Target: Cytochrome P450 (CYP450)|D1 and D5 Receptors|D2 Receptors|D3 Receptors|D4 Receptors

Summary: Calcium channel protein inhibitor
B2235 Clozapine

Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 Receptors

Summary: 5-HT receptor antagonist

insoluble in H2O; ≥14.95 mg/mL
B2240 Olanzapine

Target: 5-HT2 Receptors|D2 Receptors

Summary: Antagonist of 5-HT2A and dopamine D2 receptors

insoluble in H2O; ≥15.6 mg/mL
B2232 Aripiprazole

Target: 5-HT1 Receptors

Summary: 5-HT receptor partial agonist

≥22.4 mg/mL
B1001 Loxapine
1 Citation

Target: 5-HT2 Receptors

Summary: 5-HT receptor antagonist

≥55.6 mg/mL
B1490 Quetiapine Fumarate
1 Citation

Target: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|5-HT7 Receptors

Summary: Dopamine receptor antagonist

insoluble in H2O; insoluble in EtOH; ≥11.03 mg/mL
B1477 Lurasidone HCl

Target: 5-HT2 Receptors|D2 Receptors|5-HT1 Receptors|5-HT7 Receptors

Summary: Dopamine D2/5-HT2A/5-HT7/5-HT1A inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.11 mg/mL
B1485 Pergolide mesylate

Target: D1 and D5 Receptors|D2 Receptors

Summary: Dopaminergic agonist

insoluble in EtOH; insoluble in H2O; ≥6.84 mg/mL